What is the ticker symbol for Strongbridge Biopharma?

Strongbridge Biopharma trades under the ticker SBBP on NASDAQ.

What sector does Strongbridge Biopharma operate in?

Strongbridge Biopharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze SBBP in a portfolio?

PortView shows SBBP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Strongbridge Biopharma (SBBP) Stock Analysis

NASDAQHealthcareBiotechnology

$2.00+1.52%

1-year price historyRange $1.97 – $2.27

52-week range$2.00

$1.85$4.26

What Strongbridge Biopharma does

Strongbridge Biopharma plc is a biopharmaceutical firm actively engaged in both creating and marketing treatments for rare conditions where patient needs are currently not met. As a commercial-stage entity, its portfolio includes Keveyis, an orally administered carbonic anhydrase inhibitor approved in the United States for addressing hyperkalemic, hypokalemic, and other forms of primary periodic paralysis. The company's development pipeline features several clinical-stage compounds: Recorlev, a cortisol synthesis inhibitor currently undergoing Phase III clinical trials for the management of endogenous Cushing's syndrome, and Veldoreotide, a somatostatin analog, which has successfully completed Phase II clinical trials for acromegaly. Previously known as Cortendo plc, the company rebranded itself as Strongbridge Biopharma plc in September 2015. Established in 1996, Strongbridge Biopharma plc maintains its corporate headquarters in Trevose, Pennsylvania.

Key metrics

Market cap

P/E (TTM)

0.00

EPS (TTM)

$0.00

Beta

1.60

Dividend yield

0.00%

Revenue / share

$0.55

50-day avg

$2.14

200-day avg

$2.48

52-week high

$4.26

52-week low

$1.85

CEO

Matthew Pauls

ETFs linked to SBBP

Broad-market and Healthcare sector ETFs an investor holding Strongbridge Biopharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how SBBP fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SBBP in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Strongbridge Biopharma?: Strongbridge Biopharma trades under the ticker SBBP on NASDAQ.
Which exchange is SBBP listed on?: SBBP is listed on NASDAQ.
What sector does Strongbridge Biopharma operate in?: Strongbridge Biopharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze SBBP in a portfolio?: PortView shows SBBP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.